Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Cancer. 2018 May 14;124(15):3240–3248. doi: 10.1002/cncr.31538

Table 1.

Sample characteristics: Demographic, general health, CLL risk, behavioral correlates of inflammation, and stress scores for trial patients (N=152) and subset with immune data (N=96)

Characteristic Trial patients
(n=152)
Patients with cytokine/chemokine data
(n=96)

Demographic M/SD N (%) M/SD N (%)
 Age (in years), M (SD) 64.1 (10.80) 64.2 (10.40)
 Gender (Male) 107 (71%) 64 (67%)
 Married/Partnered (Yes) 131 (86%) 83 (87%)
 Distance from cancer center (in miles) 341.44 (438.05) 331.55 (422.58)
 Race
  Caucasian 147 (97%) 95 (99%)
  African-American 5 (3%) 1 (1%)
 Education
  High School/Technical School or Below 44 (29%) 18 (19%)
  Some College/College Graduate 58 (38%) 44 (46%)
  Some Graduate School/Graduate Degree 46 (30%) 32 (33%)
  Missing 4 (3%) 2 (2%)
 Household income (K)
  ≤ 50 41 (27%) 29 (30%)
  51-100 38 (25%) 23 (24%)
  >100 46 (30%) 43 (45%)
  Prefers Not to Answer 24 (16%) 10 (10%)
  Missing 3 (2%) 2 (2%)

General Health
  Charlson Comorbidity Index (unadjusted) 2.5 (1.0) 2.49 (0.82)

CLL Risk
  Number of prior therapies 3.5 (2.6) 3.27 (2.43)
  Del17p 78 (51%) 54 (56%)

Behavioral Correlates of Inflammation
  Body Mass Index 26.5 (4.8) 26.13 (5.10)
  Smoking Status (Current Smoker) 8 (5%) 5 (5%)

Stress (IES) 11.61 (10.55) 13.55 (10.62)

Abbreviations: Del17p = presence of deletion of 17p; IES = Impact of Event Scale